Impact of inflammatory infiltration and viral genome presence in myocardium on the changes of echocardiographic parameters

Cor et Vasa

Volumn 55, Issue 4, 2013, Pages

  Krejčí, Jan ^a   Poloczková, Hana ^a   Hude, Petr ^a   Freiberger, Tomáš ^b   Němcová, Eva ^a,b   Žampachová, Víta ^a   Sirotková, Alžběta ^a   Štěpánová, Radka ^a   Spinarová, Lenka ^a   Němec, Petr ^a,b   Vítovec, Jiří ^a  

^a ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^b Centre for Cardiovascular Surgery and Transplantation   (Czech Republic)

Author keywords

Dilated cardiomyopathy; Endomyocardial biopsy; Inflammatory cardiomyopathy; Myocarditis

Indexed keywords

ADULT; ARTICLE; CD3+ T LYMPHOCYTE; CELL INFILTRATION; CONGESTIVE CARDIOMYOPATHY; ECHOCARDIOGRAPHY; FOLLOW UP; FUNCTIONAL STATUS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; INFLAMMATION; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; MYOCARDITIS; NEW YORK HEART ASSOCIATION CLASS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; VIRUS GENOME;

EID: 84888347173     PISSN: 00108650     EISSN: 18037712     Source Type: Journal    
DOI: 10.1016/j.crvasa.2013.02.003     Document Type: Article

References (40)

1. J. Stehlik, L.B. Edwards, A.Y. Kucheryavaya, et al., The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report - 2010, Journal of Heart and Lung Transplantation 29 (2010) 1089-1103.
2. L. Dellefave, E.M. McNally, The genetics of dilated cardio-myopathy, Current Opinion in Cardiology 25 (2010) 198-204.
3. U. Kühl, M. Pauschinger, M. Noutsias, et al., High prevalence of viral genomes and multiple viral infections in the myocardium of adults with idiopathic left ventricular dysfunction, Circulation 111 (2005) 887-893.
4. L.T. Cooper, The heat is off: immunosuppression for myocarditis revisited, European Heart Journal 30 (2009) 1936-1939.
5. U. Kühl, H.P. Schultheiss, Myocarditis, Deutsches Ärzteblatt International 109 (2012) 361-368.
6. A. D'Ambrosio, G. Patti, A. Manzoli, et al., The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review, Heart 85 (2001) 499-504.
7. L.T. Cooper, Myocarditis, New England Journal of Medicine 360 (2009) 1526-1538.
8. U. Kühl, Antiviral treatment of myocarditis and acute dilated cardiomyopathy, Heart Failure Clinics 1 (2005) 467-474.
9. I. Kindermann, M. Kindermann, R. Kandolf, et al., Predictors of outcome in patients with suspected myocarditis, Circulation 118 (2008) 639-648.
10. U. Kühl, M. Pauschinger, P.L. Schwimmbeck, et al., Interferon-b treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction, Circulation 107 (2003) 2793-2798.
11. A.L. Caforio, F. Calabrese, A. Angelini, et al., A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis, European Heart Journal 28 (2007) 1326-1333.
12. R. Dennert, H.J. Crijns, S. Heymans, Acute viral myocarditis, European Heart Journal 29 (2008) 2073-2082.
13. H.P. Schultheiss, U. Kühl, What are the current treatment options for myocarditis?, Dialogues in Cardiovascular Medicine 14 (2009) 187-193.
14. U. Kühl, M. Noutsias, B. Seeberg, H.P. Schultheiss, Immuno-histological evidence for chronic intramyocardial inflammatory process in dilated cardiomyopathy, Heart 75 (1996) 295-300.
15. B. Maisch, B. Bultman, S. Factor, World Heart Federation consensus conference's definition on inflammatory cardiomyopathy (myocarditis): report from two expert committees on histology and viral cardiomyopathy, Heartbeat 4 (1999) 3-4.
16. A. Frustaci, M.A. Russo, C. Chimenti, Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study, European Heart Journal 30 (2009) 1995-2002.
17. I. Kindermann, C. Barth, F. Mahfoud, et al., Update on myocarditis, Journal of the American College of Cardiology 59 (2012) 779-792.
18. R.M. Lang, M. Bierig, R.B. Devereux, et al., Recommendations for chamber quantification, European Journal of Echocardiography 7 (2006) 79-108.
19. R. Wojnicz, E. Nowalany-Kozielska, C. Wojciechowska, et al., Randomized, placebo controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy, Circulation 104 (2001) 39-45.
20. L.T. Cooper, Myocarditis, Dialogues in Cardiovascular Medicine 14 (2009) 155-168.
21. H.P. Schultheiss, U. Kühl, L.T. Cooper, The management of myocarditis, European Heart Journal 32 (2011) 2616-2625.
22. M.G. Friedrich, U. Sechtem, J. Schultz-Menger, et al., Cardiovascular magnetic resonance in myocarditis: a JACC White paper, Journal of the American College of Cardiology 17 (2009) 1475-1487.
23. H. Baccouche, H. Mahrholdt, G. Meinhardt, et al., Diagnostic synergy of non-invasive cardiovascular magnetic resonance and invasive endomyocardial biopsy in troponin-positive patients without coronary artery disease, European Heart Journal 30 (2009) 2869-2879.
24. M.A. Olimulder, J. van Es, M.A. Galjee, The importance of cardiac MRI as a diagnostic tool in viral myocarditis-induced cardiomyopathy, Netherlands Heart Journal 17 (2009) 481-486.
25. L.T. Cooper, K.L. Baugham, A.M. Feldman, et al., The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology, Circulation 116 (2007) 2216-2233.
26. A. Yilmaz, I. Kindermann, M. Kindermann, et al., Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance, Circulation 122 (2010) 900-909.
27. M. Noutsias, M. Pauschinger, H.P. Schultheiss, U. Kühl, Advances in the immunohistological diagnosis of inflammatory cardiomyopathy, European Heart Journal Supplements 4 (2002) I54-I62.
28. H.T. Aretz, Myocarditis: the Dallas criteria, Human Pathology 18 (1987) 619-624.
29. J.W. Mason, J.B. Ó Connell, A. Herskowitz, et al., A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators, New England Journal of Medicine 333 (1995) 269-275.
30. K.L. Baughman, Diagnosis of myocarditis: death of Dallas criteria, Circulation 113 (2006) 593-595.
31. O. Zimmermann, M. Kochs, T.P. Zwaka, et al., Myocardial biopsy based classification and treatment in patients with dilated cardiomyopathy, International Journal of Cardiology 104 (2005) 92-100.
32. F. Kuethe, J. Lindner, K. Matsche, et al., Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis, Clinical Infectious Diseases 49 (2009) 1660-1666.
33. L.A. Blauwet, L.T. Cooper, Myocarditis, Progress in Cardiovascular Diseases 52 (2010) 274-288.
34. U. Lotze, R. Egerer, B. Glück, et al., Low level myocardial parvovirus B19 persistence is a frequent finding in patients with heart disease but unrelated to ongoing myocardial injury, Journal of Medical Virology 82 (2010) 1449-1457.
35. F. Escher, S. Modrow, T. Sabi, et al., Parvovirus B19 profiles in patients with acute myocarditis and chronic dilated cardiomyopathy, Medical Science Monitor 14 (2008) 589-597.
36. S.C. Koepsell, D.R. Anderson, S.J. Radio, Parvovirus is a bystander in adult myocarditis, Cardiovascular Pathology 21 (6) (2012) 476-481.
37. G.C. Stewart, J. Lopez-Molina, R.V. Gottumukkala, et al., Myocardial parvovirus B19 persistence: lack of association with clinicopathologic phenotype in adults with heart failure, Circulation: Heart Failure 4 (2011) 71-78.
38. C.T. Bock, K. Klingel, R. Kandolf, Human parvovirus B19-associated myocarditis, New England Journal of Medicine 362 (2010) 1248-1249.
39. A. Frustaci, C. Chimenti, F. Calabrese, et al., Immunosuppressive therapy for active lymphocytic myocarditis. Virological and immunologic profile of responders versus nonresponders, Circulation 107 (2003) 857-886.
40. O. Zimmermann, C. Rodewald, M. Radermacher, et al., Interferon b-1b therapy in chronic viral dilated cardiomyopathy - is there a role for specific therapy?, Journal of Cardiac Failure 16 (2010) 348-356.